Danaher Net Change in Short-term Investments 2010-2025 | DHR
Danaher annual/quarterly net change in short-term investments history and growth rate from 2010 to 2025. Net change in short-term investments can be defined as the net cash flows from the sale and purchase of investments defined to be short-term, generally with maturities of less than one year from the purchase date.
- Danaher net change in short-term investments for the quarter ending June 30, 2025 was $0M, a 0% increase year-over-year.
- Danaher net change in short-term investments for the twelve months ending June 30, 2025 was $0M, a 0% increase year-over-year.
- Danaher annual net change in short-term investments for 2024 was $0B, a 0% decline from 2023.
- Danaher annual net change in short-term investments for 2023 was $0B, a 0% decline from 2022.
- Danaher annual net change in short-term investments for 2022 was $0B, a 0% decline from 2021.
| Danaher Annual Net Change in Short-term Investments (Millions of US $) |
|
|---|---|
| 2024 | $N/A |
| 2023 | $N/A |
| 2022 | $N/A |
| 2021 | $N/A |
| 2020 | $N/A |
| 2019 | $N/A |
| 2018 | $N/A |
| 2017 | $N/A |
| 2016 | $N/A |
| 2015 | $N/A |
| 2014 | $N/A |
| 2013 | $N/A |
| 2012 | $N/A |
| 2011 | $N/A |
| 2010 | $N/A |
| 2009 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $135.913B | $23.875B |
| Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVS Health (CVS) | United States | $77.267B | 9.60 |
| Elevance Health (ELV) | United States | $63.437B | 8.53 |
| Cencora (COR) | United States | $56.784B | 19.75 |
| DiDi Global (DIDIY) | China | $26.545B | 28.20 |
| Labcorp Holdings (LH) | United States | $21.098B | 17.11 |
| Natera (NTRA) | United States | $19.106B | 0.00 |
| BioMerieux (BMXMF) | France | $15.985B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.371B | 0.00 |
| Medpace Holdings (MEDP) | United States | $13.731B | 35.52 |
| CochLear (CHEOY) | Australia | $13.060B | 0.00 |
| ICON (ICLR) | Ireland | $13.042B | 12.12 |
| Solventum (SOLV) | United States | $12.616B | 13.35 |
| Revvity (RVTY) | United States | $11.331B | 19.50 |
| Viatris (VTRS) | United States | $10.845B | 3.73 |
| Sonic Healthcare (SKHHY) | Australia | $8.965B | 0.00 |
| Avantor (AVTR) | United States | $8.872B | 12.89 |
| HealthEquity (HQY) | United States | $8.424B | 36.90 |
| Charles River Laboratories (CRL) | United States | $8.024B | 15.72 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.706B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $5.059B | 29.79 |
| BrightSpring Health Services (BTSG) | United States | $3.542B | 32.50 |
| Sotera Health (SHC) | United States | $3.225B | 18.32 |
| Surgery Partners (SGRY) | United States | $2.827B | 36.77 |
| Organon (OGN) | United States | $2.553B | 2.71 |
| Concentras Parent (CON) | United States | $2.534B | 14.64 |
| Alignment Healthcare (ALHC) | United States | $2.441B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.308B | 88.90 |
| Progyny (PGNY) | United States | $1.970B | 43.36 |
| GoodRx Holdings (GDRX) | United States | $1.757B | 35.14 |
| PACS (PACS) | United States | $1.750B | 0.00 |
| Premier (PINC) | United States | $1.738B | 13.19 |
| Ardent Health (ARDT) | United States | $1.503B | 6.41 |
| Teladoc Health (TDOC) | United States | $1.477B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.257B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.094B | 8.33 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.902B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.846B | 290.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.763B | 7.14 |
| CareDx (CDNA) | United States | $0.725B | 11.32 |
| Embecta (EMBC) | United States | $0.625B | 4.21 |
| Nutex Health (NUTX) | United States | $0.556B | 8.41 |
| So-Young (SY) | China | $0.541B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.524B | 0.00 |
| SBC Medicals (SBC) | United States | $0.516B | 0.00 |
| Omada Health (OMDA) | $0.495B | 0.00 | |
| Auna S.A (AUNA) | Luxembourg | $0.471B | 10.62 |
| LifeMD (LFMD) | United States | $0.471B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.468B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.414B | 0.00 |
| Enhabit (EHAB) | United States | $0.342B | 28.17 |
| Oncology Institute (TOI) | United States | $0.316B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.287B | 0.00 |
| Beauty Health (SKIN) | United States | $0.231B | 0.00 |
| DocGo (DCGO) | United States | $0.149B | 24.33 |
| Pheton Holdings (PTHL) | China | $0.148B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.109B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| KindlyMD (NAKA) | United States | $0.067B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| Biodesix (BDSX) | United States | $0.053B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.051B | 0.00 |
| ModivCare (MODV) | United States | $0.046B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.020B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.016B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |